REGENTS OF THE UNIVERSITY OF CALIFORNIA - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
REGENTS OF THE UNIVERSITY OF CALIFORNIA ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,523,733
-22.5%
111,4400.0%0.45%
-20.6%
Q2 2023$4,544,523
+9.4%
111,4400.0%0.57%
-26.3%
Q1 2023$4,153,369
+6.8%
111,4400.0%0.77%
+4.7%
Q4 2022$3,888,142
-37.7%
111,4400.0%0.74%
-41.7%
Q3 2022$6,236,000
+8.1%
111,4400.0%1.26%
+9.3%
Q2 2022$5,768,000
-28.8%
111,4400.0%1.16%
-4.9%
Q1 2022$8,098,000
-38.5%
111,4400.0%1.22%
-34.1%
Q4 2021$13,177,000
-11.9%
111,4400.0%1.85%
+4.9%
Q3 2021$14,950,000
-17.1%
111,4400.0%1.76%
-23.6%
Q2 2021$18,043,000
+101.7%
111,4400.0%2.30%
+97.5%
Q1 2021$8,944,000
+47.5%
111,4400.0%1.17%
+33.1%
Q4 2020$6,062,000
+173.7%
111,4400.0%0.88%
+184.4%
Q3 2020$2,215,000
-5.4%
111,4400.0%0.31%
-6.4%
Q2 2020$2,342,000
+71.8%
111,4400.0%0.33%
+62.1%
Q1 2020$1,363,000
-16.6%
111,4400.0%0.20%
-76.5%
Q4 2019$1,635,000
+9.9%
111,4400.0%0.86%
-69.7%
Q3 2019$1,488,000
-18.4%
111,4400.0%2.85%
-44.7%
Q2 2019$1,824,000
-83.5%
111,440
-78.7%
5.15%
-80.2%
Q1 2019$11,060,000
+54.5%
524,4230.0%26.04%
+50.4%
Q4 2018$7,158,000
-52.3%
524,4230.0%17.31%
-40.7%
Q3 2018$15,009,000
+4.6%
524,4230.0%29.21%
-22.2%
Q2 2018$14,348,000
+29.7%
524,4230.0%37.54%
+85.2%
Q1 2018$11,060,000
+9.7%
524,4230.0%20.28%
+33.4%
Q4 2017$10,079,000524,42315.19%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders